Showing 1 - 4 results of 4 for search 'Hongli Du', query time: 0.02s
Refine Results
-
1
-
2
-
3
-
4
Targeting oncogenic activation of FLT3/SREBP/FASN promotes the therapeutic effect of quizartinib involving disruption of mitochondrial phospholipids by Feng Yin, Jing Yang, Hao Luo, Tiantian Yu, Wenhua Lu, Mingyue Zhao, Hongli Du, Shijun Wen, Peng Huang, Yumin Hu
Published 2025-04-01Get full text
Article